Trial intelligence / Profile preview

Effectiveness of inhaled salbutamol in transient tachypnoea of the newborn

IRCT2017081414333N80Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of salbutamol in transient tachypnea of the newborn (TTN), sponsored by Kermanshah University of Medical Sciences. Started Sep 2017; status: completed.

02

Drugs

salbutamol
03

Conditions

transient tachypnea of the newborn (TTN)

Beyond the preview

Go deeper on IRCT2017081414333N80.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017081414333N80.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call